Skip to main content
. Author manuscript; available in PMC: 2021 Mar 19.
Published in final edited form as: Acta Diabetol. 2018 Jan 30;55(6):519–529. doi: 10.1007/s00592-018-1105-3

Table 3.

Associations of the elevated 1-h glucose ≥ 155 mg/dL (8.6 mmol/L) with biologic markers and subclinical target organ damage

Impaired β-cell function
Insulin resistance
Adiposity
High lipid ratios
Increased WBC
Increased fibrinogen
Subclinical target organ damage
 Subclinical atherosclerosis
 Subclinical inflammation
 Arterial stiffness
 Carotid intima-media thickness
 Left ventricular hypertrophy
 Decline in kidney function
 Fatty liver